Upadacitinib is a pharmaceutical raw material that functions as a Janus kinase inhibitor. It is used in the manufacturing of medications that modulate inflammatory processes.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 1310726-60-3
Upadacitinib
Janus kinase inhibitor active pharmaceutical ingredient
Upadacitinib hemihydrate
active pharmaceutical ingredient
N-(cis-3-(Methyl(7H-pyrrolo(2,3-d)pyrimidin-4-yl)amino)cyclobutyl)-1-propanesulfonamide
Janus kinase inhibitor
Peficitinib
Janus kinase inhibitor
Baricitinib
Janus kinase inhibitor
1-Methylpyrrolidin-3-yl 2-cyclopentyl-2-hydroxy-2-phenylacetate
active pharmaceutical ingredient
2-[(4,6-Dimethyl-2-pyrimidinyl)oxy]-3,3-diphenyl-2-propenoic Acid
active pharmaceutical ingredient impurity
Erythromycin oxime
semi-synthetic macrolide antibiotic
(3S,4R)-3-ethyl-4-(1,5,7,10-tetrazatricyclo[7.3.0.02,6]dodeca-2(6),3,7,9,11-pentaen-12-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide
WYQFJHHDOKWSHR-MNOVXSKESA-N
CC[C@@H]1CN(C[C@@H]1C2=CN=C3N2C4=C(NC=C4)N=C3)C(=O)NCC(F)(F)F